Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04125862 · ClinicalTrials.gov registry record · NA
Pain in Fibrous Dysplasia
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT04125862 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 37 participants.
The verdict
NCT04125862, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
Pain remains a common and frequently debilitating symptom, particularly during adulthood of Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS). For many FD/MAS patients, the amount of pain perceived is not commensurate with the level of detectable musculoskeletal pathology. Using a combination of clinical and biological assessments, this investigation aims to understand what drives pain in FD/MAS.
Interventions
- DIAGNOSTIC_TEST MRI-based Neuroimaging
- DIAGNOSTIC_TEST Non-contrast MRI
- DIAGNOSTIC_TEST 18F-FDG-PET/CT
- DIAGNOSTIC_TEST 18F-NaF-PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2021-01-05 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04125862
The ClinicalTrials.gov registry entry for NCT04125862 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which MRI-based Neuroimaging is the first listed.
NCT04125862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04125862 about?
NCT04125862 is a clinical study titled "Pain in Fibrous Dysplasia". Pain remains a common and frequently debilitating symptom, particularly during adulthood of Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS). For many FD/MAS patients, the amount of pain perceived is not commensurate with the level of detectable musculoskeletal pathology. Using a combination of c...
What is the current status of trial NCT04125862?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2021-01-05. Estimated completion is 2025-12-01.
What interventions are being tested in trial NCT04125862?
The interventions under investigation include: MRI-based Neuroimaging (DIAGNOSTIC_TEST), Non-contrast MRI (DIAGNOSTIC_TEST), 18F-FDG-PET/CT (DIAGNOSTIC_TEST), 18F-NaF-PET/CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04125862?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.